tiprankstipranks
Cynata Therapeutics Limited (CYYNF)
:CYYNF
US Market

Cynata Therapeutics Limited (CYYNF) Income Statement

Compare
4 Followers

Cynata Therapeutics Limited Income Statement

Last quarter (Q4 2024), Cynata Therapeutics Limited's total revenue was AU$-230.07K, a decrease of -128.77% from the same quarter last year. In Q4, Cynata Therapeutics Limited's net income was AU$-5.20M. See Cynata Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 2.32MAU$ 1.65MAU$ 7.77MAU$ 1.55MAU$ 7.01M
Gross Profit
AU$ 2.32MAU$ 1.37MAU$ 7.49MAU$ 1.27MAU$ 6.73M
Operating Expenses
AU$ 11.12MAU$ 16.26MAU$ 6.62MAU$ 8.80MAU$ 10.23M
Depreciation and Amortization
AU$ 279.96KAU$ 279.96KAU$ 279.96KAU$ 279.96KAU$ 280.73K
EBITDA
AU$ -9.95MAU$ -15.65MAU$ -6.00MAU$ -8.80MAU$ -5.87M
Operating Income
AU$ -8.81MAU$ -16.54MAU$ -6.90MAU$ -9.08MAU$ -10.51M
Other Income/Expenses
AU$ -3.25MAU$ 610.71KAU$ 622.45KAU$ 1.39MAU$ 4.36M
Pretax Income
AU$ -12.06MAU$ -15.93MAU$ -6.28MAU$ -9.08MAU$ -6.15M
Net Income
AU$ -9.74MAU$ -14.28MAU$ -5.45MAU$ -7.69MAU$ -3.64M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -0.05AU$ -0.10AU$ -0.04AU$ -0.06AU$ -0.03
Diluted EPS
AU$ -0.05AU$ -0.10AU$ -0.04AU$ -0.06AU$ -0.03
Weighted Average Shares Outstanding
179.63M 145.09M 143.28M 130.43M 104.82M
Weighted Average Shares Outstanding (Diluted)
179.63M 145.09M 143.28M 130.43M 104.82M
Currency in AUD

Cynata Therapeutics Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis